Boxer Capital’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
NMC
AG
EC
OCA
AVM
PAI
PIM
Boxer Capital's GOSS Position: Q4 2023 in Review
Boxer Capital sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 6,497,700 shares — an estimated $5.41M sold.
Boxer Capital first reported a position in GOSS in Q1 2019 and held it in 19 quarters. The position peaked at $42.8M in Q3 2022. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.
- Boxer Capital reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
- Boxer Capital sold 6,497,700 Gossamer Bio shares in Q4 2023, an estimated $5.41M.
- Boxer Capital first reported a position in Gossamer Bio in Q1 2019 and held it in 19 quarters.
- Boxer Capital's Gossamer Bio position peaked at $42.8M in Q3 2022.
- 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.
Based on Boxer Capital's 13F filing for Q4 2023, filed 14 Feb 2024.